Post

New research · Ophthalmology
Cureus · 2d
Case reportCureus · 2026

Visual Rehabilitation of Bilateral Keratoconus With Customized Scleral Lenses: A Case Report.

Nabila Y Al-Tamimi, Mohammed Amer, Fadila Nour Elrihen Graini, Ramdas Gore
Read paper
OphthalmologyCase report

Scleral lenses restored 20/20 vision in both eyes in advanced bilateral keratoconus.

Visual Rehabilitation of Bilateral Keratoconus With Customized Scleral Lenses: A Case Report.

Nabila Y Al-Tamimi … Ramdas Gore
Cureus · 2026
Background

The clinical management and visual rehabilitation of a 24-year-old female with bilateral keratoconus (OD > OS) successfully fitted with scleral lenses is presented.

Purpose

Refraction revealed +3.00 -5.00 × 105 in OD and +1.50 -3.00 × 080 in OS.

6/6 (20/20)
Results
6/6 (20/20)
eye chart reading with lenses on: both eyes reached normal, sharp vision
More results

Diagnostic scleral lenses were selected based on sagittal depth, guided by Kmax values.

Topographic analysis revealed advanced ectatic changes in OD (Kmax: 70.80 D; enhanced ectasia score: 17.99 D).

“
Conclusion

This case highlights the clinical value of scleral lenses as a reliable approach for managing irregular corneas and progressive ectasia.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving